Although this cell line has proved useful in supporting high-throughput studies, it is IDH wild-type (thus contrasting expectations for an oligodendroglioma-derived line) and lacks expression of stemness-related genes commonly observed in glioma stem-like cells (GSCs) such as CD133, nestin, and Olig2 (17). This evidence concerns the gene IDH2 and central nervous system cancer.